Clinical Trials
3 trialsNCT05703971 2026-06-03
Acclaim-3
Genprex, Inc.
Phase 1/2 Recruiting
NCT07227597 2026-05-28
MK-6070-003
Merck Sharp & Dohme LLC
Phase 1/2 Recruiting
NCT05680922 2026-03-24
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
Legend Biotech USA Inc
Phase 1 Active not recruiting